Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:13 PM UTC
| NCT Number | NCT07520006 |
| Recruiting Status | Recruiting |
| Condition | B-cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Nurix Therapeutics, Inc. |
| Last Updated on CT.gov | August 28, 2026 (Yesterday) |
As of August 29, 2026: Clinical trial NCT07520006 is currently recruiting participants. This phase1 study for b-cell lymphoma is actively seeking new participants at 6 locations across the United States. The study is sponsored by Nurix Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07520006 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07520006 was last updated Yesterday (August 28, 2026). HelloStudys verifies this status automatically.